ghk-cu hair growth evidence study GHK Peptide Clinical Trial (2016) — Research Summary ghk-cu copper peptide hair growth

Initially, three patients in the loading dose group and seven in the no loading dose group had GDS scores 5, decreasing to two patients in each group by study end

Always verify current clinical-trial and regulatory status through primary sources such as ClinicalTrials.gov, PubMed, and the FDA.

The peptide appeared to lead to a significant attenuation of TBI-induced damage and improved early outcomes based on the observed experiments

Different investigations may utilize different formulations, dosing approaches, or treatment durations, making it challenging to compare results across studies and establish optimal therapeutic protocols